
The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA …
2022年5月11日 · Here, we report that in HepG2 cells, JQ1 significantly reduced various proliferation-related lncRNAs, but up-regulated the known liver tumor marker, MALAT1. Using ChIP-sequencing data, ChIP-qPCR, luciferase reporter assays, and chromatin conformation capture (3C), we characterized the MALAT1 gene locus.
Dual transcriptome sequencing reveals resistance of TLR4 ligand ...
2015年11月19日 · Our RNA-seq data revealed that JQ1 treatment inhibited the expression of important chemokines in LPS-activated BMDMs, for example, Ccl2, Ccl5, Ccl12, Ccl22, Cxcl3, Cxcl9 and Cx3cl1 .
BET protein inhibitor JQ1 downregulates chromatin ... - Nature
2020年3月10日 · Combinational analysis of ATAC-seq and RNA-seq data discovered NID1 as the downstream target of JQ1 and JQ1 reduced NID1 expression in GC cells. Chromatin immunoprecipitation, luciferase...
Bromodomain inhibitor JQ1 reversibly blocks IFN-γ production …
2019年7月16日 · Here, we show that JQ1 represses IFN-γ expression in TH1 polarized PBMC cultures, CD4+ memory T cells, and NK cells. JQ1 treatment does not reduce activating chromatin marks at the IFNG locus,...
RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1 ...
2015年2月24日 · The present study was aimed at evaluating the anti-inflammatory function and underlying genes targeted by JQ1 in lipopolysaccharide (LPS)-stimulated BV-2 microglial cells using two transcriptomic techniques: global transcriptomic biological duplicate RNA sequencing and quantitative real-time PCR.
The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA
2022年5月11日 · Gene network analyses have implicated long non-coding RNAs (lncRNAs) in the effects of JQ1, but the precise molecular events remain unexplored. Here, we report that in HepG2 cells, JQ1 significantly reduced various proliferation-related lncRNAs, but up-regulated the known liver tumor marker, MALAT1.
The BET inhibitor JQ1 suppresses tumor survival by ABCB5
2024年10月24日 · JQ1 inhibited cell proliferation, migration and invasion, induced cell cycle arrest and promoted apoptosis. JQ1 also suppressed the survival of UM in heterotopic tumor model. RNA sequencing indicated that JQ1 down-regulated the expressions of ABCB5 and autophagy-related genes, which was confirmed in vitro and in vivo by western blot.
RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1 ...
2015年2月24日 · A novel synthetic BET inhibitor, JQ1, was proven to exert immunosuppressive activities by inhibiting the expression of IL-6 and Tnf-α in macrophages. However, a genome-wide search for JQ1 molecular targets is largely unexplored in microglia.
Regulation of MYC Expression and Differential JQ1 Sensitivity in
2014年1月23日 · JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt’s lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells.
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis …
In vitro, JQ1 and small interfering RNAs targeting Brd4 (siBrd4) inhibited the proliferation and self-renewal of GSCs. In vivo, JQ1 significantly inhibited the growth of xenograft GSCs tumors. The RNA-seq analysis revealed that the PI3K-AKT pathway played an important role in GBM.